PMG Wealth Management’s AbbVie ABBV Stock Holding History

PMG Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,077	Closed	-$1.67M	–	57
2025 Q3	$1.67M	Sell	7,077 -157	-2%	-$32K	1.27%	22
2025 Q2	$1.34M	Buy	+7,234	New	+$1.34M	1.11%	22

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PMG Wealth Management's ABBV Position: Q4 2025 in Review

PMG Wealth Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 7,077 shares — an estimated $1.67M sold.

PMG Wealth Management first reported a position in ABBV in Q2 2025 and held it in 2 quarters. The position peaked at $1.67M in Q3 2025. 4,158 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

PMG Wealth Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
PMG Wealth Management sold 7,077 AbbVie shares in Q4 2025, an estimated $1.67M.
PMG Wealth Management first reported a position in AbbVie in Q2 2025 and held it in 2 quarters.
PMG Wealth Management's AbbVie position peaked at $1.67M in Q3 2025.
4,158 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on PMG Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.